Screening for Chronic Kidney Disease
U.S. Preventive Services Task Force
Screening for Chronic Kidney Disease
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) evidence on screening for chronic kidney disease.
Update in ProgressIn an effort to make the USPSTF recommendations clearer and its processes more transparent, the Task Force is sharing drafts of many of its documents for public comment, including draft Research Plans and draft Recommendation Statements. As a result, the final Recommendation Statement is not yet available.
Evidence ReportThe research team at the EPC independently gathers and reviews the available published evidence to address the questions posed by the USPSTF. The resulting draft Evidence Report is critiqued by national subject matter experts before being finalized.
|Evidence Report||Related Items|
|Evidence Report (PDF File, 201 KB; PDF Help)||Comparative Effectiveness Review (PDF File, 7.5 MB; PDF Help)|
Recommendation StatementThe USPSTF reviews the Evidence Report, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more preliminary specific recommendations. The resulting draft Recommendation Statement is posted on this Web site for public comment before being finalized.
|Recommendation Statement||Related Documents|
|Draft Recommendation Statement for Public Comment |
(April 30–May 29, 2012)
|Consumer Fact Sheet (PDF File, 229 KB; PDF Help)|
Current as of April 2012
Screening for Chronic Kidney Disease, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsckd.htm
U.S. Preventive Services Task Force Opportunities for Public Comment
Available for Comment
Draft Research Plans
- There are currently no Research Plans available for public comment.
Draft Evidence Reports
- There are currently no Evidence Reports available for public comment.
Draft Recommendation Statements
Helpful InformationUSPSTF Newsroom
Tell me more about clinical preventive services.
Tell me more about the U.S. Preventive Services Task Force (USPSTF).
Tell me how the Agency for Healthcare Research and Quality supports the USPSTF.
Tell me more about the USPSTF Recommendation Statements and how they are used.
Tell me why USPSTF Recommendations are addressed to primary care providers instead of individuals.
Tell me who serves on the USPSTF and how they are selected.
Tell me how I can nominate a clinical preventive health service for the USPSTF to consider.
To learn more about and comment on USPSTF draft Research Plans or draft Recommendation Statements, continue reading below.
Research PlansA small group of USPSTF members, called topic leads, works with researchers from the Evidence-based Practice Center (EPC) to create a draft Research Plan to guide the systematic review of the evidence. The Research Plan consists of an analytic framework, key questions, and a literature search strategy or research approach.
Each draft Research Plan is posted for public comment for 4 weeks. The USPSTF topic leads, with the assistance of the EPC researchers, review all of the comments received, revise the draft plan, and develop a final Research Plan. The final Research Plan is then posted on this Web site.
Evidence ReportsThe research team at the EPC independently implements the final Research Plan by conducting a systematic review of the evidence to address the questions posed by the USPSTF. The EPC currently shares all draft Evidence Reports with a panel of external subject matter experts and revises its work based upon this feedback. In the future, the Task Force will post the draft Evidence Reports for public comment.
The research team presents the revised draft Evidence Report to the full USPSTF at one of its in-person meetings. After the meeting, based on feedback received from Task Force members, the research team finalizes the Evidence Report and prepares a manuscript summarizing the evidence for publication in a peer-reviewed journal or on this Web site.
The USPSTF, in partnership with AHRQ's Effective Health Care (EHC) Program, currently offers opportunities for public comment on EHC draft Evidence Reports that are related to the USPSTF's work. To learn more about and comment on draft Evidence Reports from AHRQ's EHC Program, visit http://effectivehealthcare.ahrq.gov/index.cfm/research-available-for-comment/.
Recommendation StatementsDuring one of its in-person meetings, the entire USPSTF reviews the evidence, evaluates the benefits and harms of the clinical preventive service, and discusses and develops one or more specific recommendations.
After the meeting, the topic leads write a full draft Recommendation Statement that includes the specific recommendations of the entire USPSTF, a rationale section, a section of clinical considerations to guide health care professionals, and a discussion section that reviews the evidence and discusses the recommendations of other organizations. The USPSTF posts its draft Recommendation Statement on this Web site for public comment for 4 weeks. The USPSTF topic leads review all of the comments received and revise the draft Recommendation Statement. The final Recommendation Statement is reviewed and voted on by the full Task Force, and posted on this Web site.
How to CommentAny visitor to this site can comment on any of the listed USPSTF draft Research Plans or draft Recommendation Statements. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences.
To comment, click on the title of the draft document in the box at top right. Comments must be received before the comment deadline listed below each title. The comment period for draft documents is 4 weeks.
Once the draft Research Plan or Recommendation Statement is removed from the public comment page, the USPSTF begins considering comments and finalizing the document. Until the final Recommendation Statement is published, the USPSTF considers the Recommendation Statements on this Web site to be current.
You will receive acknowledgement that your comments have been transmitted. At the present time, the USPSTF cannot provide responses to individual comments.
Previous Opportunities for Public Comment
|Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility (Draft Research Plan)||February 28–March 27, 2012|
|Screening for Peripheral Artery Disease (Draft Research Plan)||December 15, 2011–January 12, 2012|
|Screening for Coronary Heart Disease with Electrocardiography||November 30–December 13, 2011|
|Screening for Hearing Loss in Older Adults||November 30–December 13, 2011|
|Screening for Prostate Cancer||November 30–December 13, 2011|
|Counseling to Prevent Skin Cancer||November 8–December 6, 2011|
|Screening for Cervical Cancer||October 19–November 30, 2011|
|Screening and Management for Obesity in Adults||October 26–November 23, 2011|
|Screening for Prostate Cancer||October 11–November 8, 2011|
|Screening for Hearing Loss in Older Adults||October 4–November 1, 2011|
|Screening for Coronary Heart Disease with Electrocardiography||September 27–October 25, 2011|
|Screening and Treatment for Glaucoma||September 14–October 12, 2011|
|Counseling to Promote a Healthy Diet and Physical Activity in Adults||February 22, 2011–March 22, 2011|
|Falls Prevention in Older Adults||January 12, 2011–February 9, 2011|
|Screening for Bladder Cancer||November 30, 2010–December 28, 2010|
|Screening for Testicular Cancer||September 21, 2010–October 19, 2010|
|Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum||August 16, 2010–September 13, 2010|
|Screening for Osteoporosis||July 6, 2010–August 3, 2010|
Current as of April 2012
Opportunities for Public Comment. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/tfcomment.htm